Gilead’s oral JAK inhibitor filgotinib wins EU approval
Treatment is indicated for use in adults with moderate-to-severe active rheumatoid arthritis
28th September 2020
Latest news
First UK patient given GSK’s experimental arthritis drug in COVID-19 trial
Drug is being investigated in up to 800 hospitalised patients nationwide
28th September 2020
Monte Rosa Therapeutics raises $96m to develop protein-degrading molecules
ICR and Cancer Research UK spinout closes Series B financing
25th September 2020
UK consumers seeking advice from pharmacists during pandemic, research finds
Survey commissioned by Johnson & Johnson for World Pharmacists Day
25th September 2020
Novavax begins phase III coronavirus vaccine trial in the UK
Trial is being conducted in partnership with UK government's Vaccines Taskforce
25th September 2020
Accord Healthcare launches Herceptin biosimilar in the UK
Zercepac will be available for HER2-positive breast and gastric cancers
25th September 2020
Oncimmune partners with Genentech to profile samples from rheumatology trials
UK-headquartered company will characterise autoantibody profiles of clinical trial patients
24th September 2020
Verona Pharma launches late-stage COPD trial programme
Phase III trial programme will evaluate nebulised ensifentrine in moderate-to-severe COPD
24th September 2020
FDA and EMA accept regulatory submissions for UCB’s bimekizumab
UCB is seeking approval for treatment in moderate-to-severe plaque psoriasis
24th September 2020
NHS COVID-19 app launches in England and Wales
App will automatically alert users when they come into close contact with someone with the virus
24th September 2020
Digital tech has health benefits for dementia patients, project finds
The Leeds Dementia Pathfinder project supported patients and carers with tech devices
23rd September 2020
Owlstone Medical’s breath biopsy test improves detection of liver disease
Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis
23rd September 2020
Vertex, CRISPR Therapeutics’ sickle cell gene therapy wins PRIME designation
European Medicines Agency grants designation based on phase I/II data
23rd September 2020
Sanofi, GSK ink deal with EU for 300 million COVID-19 vaccine doses
Upfront funding will be used to scale-up manufacturing
23rd September 2020
Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers
Data presented at 2020 ESMO virtual congress
22nd September 2020
